# OnCo record mythic-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/mythic-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "mythic-therapeutics" ;
  schema:name "Mythic Therapeutics"@en ;
  schema:description "Mythic Therapeutics designed antibody-drug conjugates, antibodies that carry a cell-killing drug into tumours, with an engineering trick to get more drug inside cancer cells. Its lead lung cancer medicine reached mid-stage trials before the company wound down in late 2025."@en ;
  schema:url <https://onco.cc/companies/mythic-therapeutics/>, <https://mythictherapeutics.com/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://mythictherapeutics.com/>, <https://www.biospace.com/mythic-therapeutics-launches-with-new-approach-to-improving-antibody-drug-conjugate-performance-backed-by-103-million-in-series-b-financing>, <https://www.biospace.com/press-releases/sale-of-intellectual-property-mythic-therapeutics-inc> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/nsclc/> ;
  onco:sections <https://onco.cc/fronts/adcs/> ;
  onco:technologies <https://onco.cc/technologies/adc/> ;
  onco:targets <https://onco.cc/targets/met/> .